Gene Query: PYROXD1

Dataset Description Geneva Score
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 45.58
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 26.39
Ebola virus (EBOV) infection of ARPE-19 cells 22.22
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 21.08
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 17.31
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 17.05
Toxoplasma gondii infection of human retinal pigment epithelial cells 16.91
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 16.71
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 16.71
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 15.9
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 15.83
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 15.74
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 15.19
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 14.77
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 14.13
Genome wide miR-191 target profile determined by RIP and gene expression profiling 13.45
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 13.45
Targeting MTHFD2 in Acute Myeloid Leukemia 13.33
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 12.99
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 12.73
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 11.58
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 11.44
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 11.36
Transcriptional profiling of LS1034 cells treated with tepoxalin 10.87
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 10.48
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 9.98
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 9.98
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 9.96
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 9.78
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 9.58
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 9.56
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 9.5
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 9.28
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 9.28
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 9.19
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 9.09
The role of FAM46C in myeloma cells 8.96
The role of FAM46C in myeloma cells [sequencing] 8.96
SLIGRL-induced gene expression changes in NHEK cells 8.94
Integrating single-cell transcriptomic data across different conditions, technologies, and species 8.89
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 8.84
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 8.75
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 8.59
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 8.51
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 8.49
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 8.34
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 8.34
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 8.3
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 8.29
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 8.0
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 7.95
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 7.74
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 7.64
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 7.64
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 7.61
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 7.57
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 7.53
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 7.53
Transcriptome analysis in Neobractatin treated cells 7.47
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 7.32
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 7.12
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 6.91
The regulartory role of ZCCHC24 in splicing machinery 6.89
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 6.85
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 6.84
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 6.72
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 6.68
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 6.68
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 6.62
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 6.57
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 6.54
Overexpression of NFIB and YBX1 in MCF-7 cells 6.48
RNA-seq data from human lymphoma cell lines 6.41
ChIP-seq and RNA-seq from human lymphoma cell lines 6.41
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 6.3
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 6.25
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 6.24
CROP-Seq in Primary Human T Cells 6.16
Region-specific Innate Antiviral Responses of the Human Epididymis 6.08
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 6.03
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 5.96
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 5.9
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 5.9
Genome-wide analysis of the Integrator complex (HTS) 5.86
Genome-wide analysis of the Integrator complex 5.86
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 5.85
JunB control of keratinocyte-mediated inflammation [RNA-seq] 5.78
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 5.78
Role of microRNAs in the interaction between Salmonella and the host cell 5.66
Lysine benzoylation is a novel histone mark [RNA-seq] 5.64
Lysine benzoylation is a novel histone mark 5.64
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 5.64
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 5.59
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 5.59
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 5.52
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 5.51
MOF acetyl transferase regulates transcription and respiration in mitochondria 5.46
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 5.44
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 5.42
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 5.4
Mutational landscape of splicing genes and functional consequences across 33 cancer types 5.34
LNCaP treated with iBET 5.34
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 5.27
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 5.25
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 5.24
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 5.14
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 5.14
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 5.12
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 5.1
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 5.02
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 5.01
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 4.95
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 4.86
LncRNA expression profiling of ischemic stroke patients 4.78
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 4.78
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 4.74
Next generation sequencing of small RNAs isolated from exosomes in human semen 4.72
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 4.71
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 4.66
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 4.66
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 4.65
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 4.65
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 4.63
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 4.62
Oncogenic MYC induces a dependency on the spliceosome in human cancer 4.62
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  4.62
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 4.57
Effect of PRDM11 depletion in U2932 cells 4.54
Gene expression profiling of leukemia cells following asparagine depletion 4.52
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 4.5
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 4.4
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 4.4
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 4.36
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 4.36
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 4.35
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 4.35
RNAseq of IL-36 stimulated primary human keratinocytes 4.33
RNA-seq analyisis of PUM2 knockout cells 4.26
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 4.26
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 4.25
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 4.25
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 4.21
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 4.21
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 4.2
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 4.2
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 4.16
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 4.15
Electronic cigarettes 4.15
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 4.13
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 4.07
Epigenetic reprogramming of melanoma cells by vitamin C treatment 4.05
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 4.05
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 4.02
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 3.97
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 3.97
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 3.96
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 3.91
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 3.9
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 3.83
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 3.79
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 3.79
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 3.73
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 3.71
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 3.67
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 3.62
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 3.62
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 3.62
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 3.61
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 3.59
Uridylation by TUT4 and TUT7 marks mRNA for degradation 3.59
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 3.57
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 3.56
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 3.54
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 3.54
Illumina Total RNA-seq in HeLa 3.52
Gene expression analysis of the impact of TDP-43 knockout in human cells. 3.52
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 3.5
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 3.5
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 3.49
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 3.48
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 3.48
Discovering human diabetes-risk gene function with genetics and physiological assays 3.46
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 3.45
EWSR1 influences alternative splicing through direct and indirect mechanisms 3.44
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 3.44
Analysis of transcriptional regulation by Myt1 and Myt1l 3.42
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 3.42
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 3.41
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 3.41
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 3.4
HNRNPM-regulated splicing dependencies in prostate cancer 3.4
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 3.4
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 3.35
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 3.32
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 3.32
HNF1 regulates critical functions of the human epididymis epithelium. 3.32
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 3.31
R430: A potent inbibitor of DNA and RNA viruses 3.3
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 3.29
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 3.28
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 3.28
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 3.26
RNA-Seq of PRMT1 overexpression ECA109 cells 3.26
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 3.26
Transcriptome analysis of SKI knock-out in HL60 cells 3.26
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 3.26
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 3.25
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 3.25
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 3.23
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 3.22
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 3.13
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 3.12
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 3.09
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 3.09
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 3.09
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 3.07
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 3.06
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 3.06
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 3.05
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 3.04
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 3.04
Effect of disulfiram treatment on pediatric high grade glioma 3.04
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 3.04
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 3.03
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 3.01
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 3.0
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 2.98
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 2.98
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 2.96
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 2.96
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 2.94
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 2.94
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 2.92
Primate transcript and protein expression levels evolve under compensatory selection pressures 2.9
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 2.9
Human cell line and subcutaneous tumor 2.9
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 2.87
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 2.87
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 2.85
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 2.84
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 2.84
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 2.84
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 2.83
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 2.81
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 2.8
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 2.8
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 2.8
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 2.78
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 2.76
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 2.71
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 2.71
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 2.71
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 2.71
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 2.7
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 2.7
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 2.7
Cleavage Factor Im as a key regulator of 3’ UTR length 2.7
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 2.7
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 2.68
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 2.68
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 2.66
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 2.66
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 2.65
Molecular analysis of renal cell carcinoma with unclassfied histology 2.65
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 2.63
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 2.63
LIN28A Over-expression RNAseq 2.61
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 2.59
RNA Seq of HMVEC under hypoxia 2.59
Integrin signaling regulates YAP/TAZ to control skin homeostasis 2.58
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.58
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 2.53
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 2.51
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 2.5
MYCL and EP400 are required for Max and MCPyV mediated gene activation 2.43
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.4
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.4
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 2.39
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 2.38
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 2.37
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 2.33
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 2.29
hnRNP C is a key regulator of protein synthesis in mitosis 2.27
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 2.26
SLAM-seq for K562 endogenous mRNA decay 2.25
6mer seed toxicity in tumour suppressive microRNAs 2.24
Transcriptional landscape changes during human embryonic stem cell derivation 2.24
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 2.23
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 2.22
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.21
Transcriptomic analysis of human tonsillar TFH subsets 2.2
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 2.2
KSDM1b Role in Ewing Sarcoma 2.16
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 2.14
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 2.14
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 2.13
RNAseq of Breast cancer PDX samples 2.13
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 2.12
Human Treg IFNg/IL-10 subpopulations 2.1
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 2.09
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 2.09
HBEC-shp53-PCHD7 2.08
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 2.07
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 2.07
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 2.05
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 2.03
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 2.02
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 2.01
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 2.01
HEK293 TFAM Knockout Expression Study 2.0
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 2.0
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 1.98
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  1.95
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 1.94
ARID1A and ARID1B loss in HCT116 and TOV21G cells 1.92
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.87
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 1.87
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 1.86
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 1.85
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 1.83
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.81
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 1.79
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 1.77
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 1.76
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 1.73
The circadian transcriptional landscape in primary human mammary epithelial cells 1.72
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.71
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.71
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 1.7
Transposon-based construction of strand-specific RNA-seq libraries 1.7
Regulation of protein translation during mitosis 1.69
Role of COP1 on MAP kinase transcriptional output in melanoma 1.68
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 1.68
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 1.67
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.66
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.64
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 1.63
RNAseq Study in CC-671 Treated Cal-51 Cells 1.63
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 1.63
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 1.62
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 1.6
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 1.59
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 1.59
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 1.56
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.56
Gene expression profile of multiple myeloma cell lines treated with CB-5083 1.54
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 1.5
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 1.5
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 1.48
The cytokine environment influence on human skin-derived T cells 1.47
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 1.45
Gene expression changes due to PARP knockdown in human cells 1.44
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 1.43
Hypoxic transcriptome of SQ20B human head and neck cancer cells 1.42
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.41
Transcriptional profile in human S. haematobium infection 1.4
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 1.39
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 1.39
mRNA expression profile of Lymphocytes 1.39
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 1.37
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 1.36
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 1.36
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 1.33
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 1.31
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 1.26
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 1.26
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.25
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 1.23
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 1.21
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 1.21
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.2
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 1.2
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.19
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 1.19
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 1.18
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 1.17
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 1.16
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 1.14
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 1.13
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 1.12
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 1.12
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 1.12
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.07
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 1.06
Peptidomimetic blockade of MYB in acute myeloid leukemia 1.06
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 1.05
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 1.05
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 1.05
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 1.05
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 1.03
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 1.03
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 1.03
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 1.03
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 1.03
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.02
O-glcnAc reprograms cellular energetics 1.02
Gene expression signatures of innate lymphoid cells from human blood 1.02
Transcriptome profiling of 5 human adenocarcinoma cell lines 0.98
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 0.98
Gene expression alterations of pancreatic intraepithlial neoplasia 0.96
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.96
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 0.95
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 0.95
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 0.94
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.94
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.93
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 0.92
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 0.9
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 0.89
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 0.89
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 0.89
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 0.88
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 0.88
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.85
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 0.84
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 0.82
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.81
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 0.8
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.8
Transcription elongation regulates genome 3D structure 0.78
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.77
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.77
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.74
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 0.72
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.72
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.71
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 0.7
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 0.69
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 0.68
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 0.66
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.66
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 0.63
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 0.62
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 0.6
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 0.58
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.58
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.57
Aging-associated patterns in the expression of human endogenous retroviruses 0.57
An optimization system for isolating and sequencing of single human colon cancer cells 0.55
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.54
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.54
Transcriptome analyses of human pancreatic islets and pseudoislets 0.53
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 0.51
LIN28A modulates splicing and gene expression programs in breast cancer cells 0.51
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.5
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 0.49
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 0.49
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 0.47
RNA-seq analysis of control and Myc-induced U2OS cells 0.47
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.46
RNA-Seq from human ILC transitional populations 0.45
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 0.45
Total RNA-Seq data from leukemic patients with complex structural variants 0.44
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.43
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 0.43
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 0.43
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.42
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.42
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.42
Human Treg NaCl stimulation 0.41
p63 controls the enhancer landscape during keratinocyte differentiation 0.38
miR-93 Targets in Human Endothelial Cells 0.38
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.36
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.36
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.36
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.36
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 0.35
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 0.33
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.31
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.31
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.3
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 0.29
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.27
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 0.26
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.26
Human Treg IL-12 stimulation 0.24
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 0.21
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 0.2
mRNA recovered upon RNF219 IP. [RNA-IP] 0.18
Expression profiling of converted and control dermal BJ fibroblasts 0.18
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 0.18
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.17
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.17
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.16
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.15
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.15
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.15
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.14
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.14
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.12
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.12
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.1
Mitochondrial dsRNA triggers antiviral signalling in humans 0.1
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.09
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.07
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.06
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.06
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 0.06
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 0.05
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation